EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Hybrid Argon Plasma Coagulation in the Treatment of Barrett's Esophagus: a Meta-analysis and Systematic Review

R. Maselli, D. Massimi, M. Menini, M. Spadaccini, A. Capogreco, A. Fugazza, S. Carrara, A. Facciorusso, T. Rizkala, A. Schilirò, D. Ramai, M. Knabe und 3 weitere

Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S176

DOI: 10.1055/s-0044-1783084 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von R. Maselli und 14 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Radiofrequency ablation is a widely used technique for ablating flat dysplastic Barrett esophagus. Hybrid-APC (H-APC) is an emerging technique, which combines argon plasma coagulation with saline injection prior to ablation therapy to minimize damage to the muscular layers. Our goal was to conduct a systematic review of existing literature to assess the safety and efficacy of H-APC.

Methods

Electronic databases (Medline, Scopus, EMBASE) were searched up to July 2023. Efficacy outcomes included initial and long-term (ranging from 12 to 24 months) complete eradication of intestinal metaplasia (CEIM). Safety outcomes included the rate of adverse events, such as stricture, bleeding and perforation, and the tolerability profile. Outcomes were assessed by pooling data using a random or fixed-effect model, according to the degree of heterogeneity, to obtain a proportion with a 95% confidence interval.

Results

Six studies, enrolling 331 patients, were eligible. The overall pooled rate of initial complete eradication of intestinal metaplasia (CEIM) was 86.3% (95% C.I. 0.78940, 0.93729, I 2 =74.54%), with long-term CEIM being 75.5% (95% C.I.: 0.67639, 0.83340, I 2 =29.24%). The overall pooled rate of adverse events was 3.6% (95% C.I. 0.01602, 0.05591, I 2 =0%), with the risk of stricture, bleeding, and perforation of 3.2% (95% C.I. 0.01343, 0.05143), 0.87% (95% C.I. 0.00124, 0.01857), and 0.87% (95% C.I. 0.00124, 0.01857) respectively. The overall pooled rate of patients reporting pain and discomfort after the entire ablation cycle was 30.5% (95% C.I. 0.15289, 0.45647, I 2 =84.9%).

Conclusions

Hybrid-APC demonstrates promising efficacy and safety, with a favorable patient tolerability profile. This analysis highlights its potential role as a new ablative technique for patients with Barrett esophagus. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Maselli, R., Massimi, D., Menini, M., Spadaccini, M., Capogreco, A., Fugazza, A., Carrara, S., Facciorusso, A., Rizkala, T., Schilirò, A., Ramai, D., Knabe, M., Sharma, M., Hassan, C., & Repici, A. (2024). Hybrid Argon Plasma Coagulation in the Treatment of Barrett's Esophagus: a Meta-analysis and Systematic Review. Endoscopy, 56(S 02 S 02), S176. https://doi.org/10.1055/s-0044-1783084

Vancouver

Maselli R, Massimi D, Menini M, Spadaccini M, Capogreco A, Fugazza A, et al. Hybrid Argon Plasma Coagulation in the Treatment of Barrett's Esophagus: a Meta-analysis and Systematic Review. Endoscopy. 2024;56(S 02 S 02):S176. doi:10.1055/s-0044-1783084

BibTeX
@article{Maselli2024,
  author = {Maselli, R. and Massimi, D. and Menini, M. and Spadaccini, M. and Capogreco, A. and Fugazza, A. and Carrara, S. and Facciorusso, A. and Rizkala, T. and Schilirò, A. and Ramai, D. and Knabe, M. and Sharma, M. and Hassan, C. and Repici, A.},
  title = {Hybrid Argon Plasma Coagulation in the Treatment of Barrett's Esophagus: a Meta-analysis and Systematic Review},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {S 02 S 02},
  pages = {S176},
  doi = {10.1055/s-0044-1783084}
}
Kostenlos starten →